OakChart

Envoy Medical Inc

COCHHealthcare·Medical Devices·USA·Micro·NASD·Nov 11 • 3:59 PM ET

6.95+0.03 (0.43%)
2026-11-12 07:57 CET
Market cap
53.79 USD m
Revenue, TTM
0.23 USD m
Net income, TTM
-25.95 USD m
Free cash flow, TTM
-22.44 USD m
EPS diluted, TTM
-4.70
P/E
-
Compare

Price

COCH against its 20, 50 and 200-day averages
2050200beatearnings
Patternshover a marker to name it
Sales mean, own scale
Sales 0.05Price0.030.055.006.007.008.009.00516K1.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26COCHclose 6.9520-day 6.6450-day 6.80200-day 6.886.95

27.1% under the 52-week high of 9.54 on 17 Mar 2026. 52-week low 3.63 on 11 Feb 2026. Last 15 sessions, 58.1% high to low

Volume 3.01× normal · the line is the 50-bar volume average

Profile

COCH
52-week range, 56% of the way up
3.629.54

Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. It focuses on designing, developing, and marketing fully implantable medical devices that improve hearing. The company was founded in 1995 and is headquartered in White Bear Lake, MN.

Employees43
IPOApr 29, 2021
Beta2.01
ATR, 14d0.54
Rel volume3.01
Short float1.94%
Inst own22.96%

Snapshot

6 groups

Valuation

Index-
Market Cap53.79M
Enterprise Value40.00M
Income-25.95M
Sales0.23M
Book/sh-0.20
Cash/sh1.88
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees43
IPOApr 29, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S233.88
P/B-
P/C3.69
P/FCF-
EV/EBITDA-
EV/Sales173.92
Quick Ratio1.10
Current Ratio1.21
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-4.70
EPS next Y-2.44
EPS next Q-0.65
EPS this Y78.67%
EPS next Y7.12%
EPS next 5Y42.20%
EPS past 3/5Y7.81% -942.66%
Sales past 3/5Y0.56% -
EPS Y/Y TTM64.70%
Sales Y/Y TTM11.06%
EPS Q/Q85.83%
Sales Q/Q57.14%
EarningsNov 05 BMO
EPS/Sales Surpr.25.37% 27.66%

Ownership

Insider Own-
Insider Trans-
Inst Own22.96%
Inst Trans-
ROA-152.54%
ROE-
ROIC-
Gross Margin-352.81%
Oper. Margin-10151.52%
Profit Margin-11233.77%
SMA204.66%
SMA502.13%
SMA2001.02%
Trades-

Technical

Shs Outstand7.74M
Shs Float4.63M
Short Float1.94%
Short Ratio5.90
Short Interest0.09M
52W High9.54 -27.14%
52W Low3.62 91.72%
Volatility7.30% 9.93%
ATR (14)0.54
RSI (14)55.19
Beta2.01
Rel Volume3.01
Avg Volume15.23K
Volume45,767

Performance

Perf Week-2.39%
Perf Month5.40%
Perf Quarter-6.87%
Perf Half Y5.66%
Perf YTD5.13%
Perf Year-0.97%
Perf 3Y-26.06%
Perf 5Y-92.86%
Perf 10Y-
Recom1.00
Target Price19.67
Prev Close6.92
Price6.95
Change %0.43%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Oct 06, 2026InitiatedLLake StreetBuy$2.50-64.0%
Mar 31, 2026InitiatedHH.C. WainwrightBuy$2.50-64.0%
Jun 24, 2024InitiatedAAscendiant Capital MarketsBuy$8.50+22.3%

Peers

Mkt cap
TickerCompanyMkt cap
CVRXCVRx Inc19.95M
NPCENeuroPace Inc429.73M
INSPInspire Medical Systems Inc1.80B
NYXHNyxoah SA91.66M
ECORElectroCore Inc71.13M
LIVNLivaNova PLC5.01B
NMTCNeuroOne Medical Technologies Corp7.31M
PHGKoninklijke Philips NV ADR29.52B
IRIXIRIDEX Corp11.47M
MODDModular Medical Inc16.14M

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Patel Mona ChetanDirectorFeb 12 '26Buy0.40312,500125,000332,500Feb 17 04:51 PM
Potashnick RobertInterim CFOFeb 12 '26Buy0.40212,50085,000212,500Feb 17 04:49 PM
Kantor SusanDirectorFeb 12 '26Buy0.4096,15038,460174,037Feb 17 04:47 PM
BRYNELSEN CHARLESDirectorFeb 12 '26Buy0.401,000,000400,0001,050,000Feb 17 04:45 PM
Lucas Brent T.Chief Executive OfficerFeb 12 '26Buy0.4062,50025,000297,090Feb 17 04:45 PM
TAYLOR GLEN A10% OwnerFeb 12 '26Buy0.4018,750,0007,500,00021,703,607Feb 17 01:35 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.500-0.670-0.5000.070.053
2026Q22026-08-10-0.700-0.800-0.6990.050.052
2026Q12026-05-11-0.800-1.400-0.8270.040.101
2025Q42026-03-23-2.900--2.6740.10--
2025Q32025-11-10-3.500-2.400-3.5450.040.061
2025Q22025-07-31-3.200-3.025-3.2460.080.074
2025Q12025-05-01-2.900-3.575-2.9240.050.074
2024Q42025-03-31-5.300-3.133-3.6040.040.093
2024Q32024-11-14-3.700-2.725-3.7420.060.084
2024Q22024-08-12-2.700-2.525-2.7100.070.084
2024Q12024-05-15-3.200-2.250-3.1990.060.092
2023Q42024-04-02-1.900-1.900-2.4900.100.081
2023Q32023-11-291.3001.3001.2520.08-1
2026Q4---0.653--0.053
2027Q1---0.610--0.073
2027Q2---0.603--0.073

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY-23.800-23.400-25.4330.320.30
2024FY-14.900-12.800-14.8870.230.27
2025FY-12.300--0.24-
2026FY--2.623--0.13
2027FY--2.437--0.13
2028FY--2.375--8.65

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-093110.050.000.10
2026Q4S2026-11-053010.050.000.10
2026Q4S2026-11-033010.050.000.10
2026Q4S2026-11-023020.050.000.10
2026Q4S2026-10-093110.090.060.10
2026Q4S2026-10-053010.050.000.10
2026Q4S2026-08-202010.030.000.06
2026Q4S2026-08-102000.050.000.10
2026Q4S2026-07-242000.050.000.10
2026Q4S2026-05-111000.100.100.10
2026Q4S2026-03-301000.100.100.10
2026Q4S2025-11-121000.060.060.06
2026Q4R2026-11-05110-0.69-0.69-0.69
2026Q4R2026-11-02110-0.88-0.88-0.88

Estimate history

EPS, annual0-0.047-15.729-25.433-14.887-12.323-4.7021
Period202020212022202320242025TTM
EPS, quarterly-3.742-3.604-2.924-3.246-3.545-2.674-0.827-0.699-0.502
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual000.2370.3160.2250.2410.23
Period202020212022202320242025TTM
Sales, quarterly0.0560.0420.0460.0780.0420.0750.0390.0510.066
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual6.0385.3131.0121.862.1332.8937.744
Period202020212022202320242025MRQ
Shares, quarterly1.9732.1332.1332.1522.3812.8937.6887.7197.744
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue0.230.240.230.320.240.000.00
Cost of Goods Sold Incl. D&A1.050.870.740.790.570.000.00
Gross Profit-0.81-0.63-0.52-0.47-0.340.000.00
Selling, General and Administrative Excl. Other22.6421.6418.7417.898.375.200.00
Research and Development14.4012.4910.188.964.97--
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-23.45-22.27-19.26-18.36-8.71-5.20-0.00
Interest Expense-1.590.820.00-0.000.00
Unusual Expense-2.31-0.130.7011.627.09-4.920.00
Net Income Before Taxes-20.85-23.76-20.80-29.92-15.92-0.25-0.00
Income Taxes0.000.000.000.000.000.000.00
Consolidated Net Income-20.85-23.76-22.45-29.92-15.92-0.25-0.00
Net Income From Continuing Operations-20.85-23.76-22.45-29.92-15.92-0.25-0.00
Net Income-25.95-28.66-27.97-31.27-15.92-0.25-0.00
EPS (Recurring)-2.64-12.36-14.63-18.82-10.83-0.70-0.00
EPS (Basic, Before Extraordinaries)-4.70-12.32-14.89-25.43-15.73-0.05-0.00
EPS (Diluted)-4.70-12.32-14.89-25.43-15.73-0.05-0.00
EBITDA-23.15-21.97-19.08-18.23-8.63-5.20-0.00
Non-Operating Income (Expense)0.29-0.02-0.030.05-0.130.040.00
Other After Tax Adjustments0.000.00-1.660.000.000.000.00
Stock Option Compensation Expense0.940.660.561.570.00--
Price To Earnings Ratio---64.5332.22-115.28
Price To Sales Ratio307.6663.80119.4270.45427.99--
Gross Margin-352.81-262.66-229.78-149.68-141.77--
Operating Margin-10,151.52-9,240.66-8,558.22-5,809.81-3,673.42--
Net Margin-11,233.77-11,892.95-12,432.44-9,895.89-6,718.57--
Shares Outstanding7.742.892.131.861.015.316.04
Market Capitalization53.7953.7930.5035.40532.31517.44517.97

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.070.050.040.070.040.080.050.04
Cost of Goods Sold Incl. D&A0.240.280.310.210.200.230.230.16
Gross Profit-0.18-0.23-0.27-0.14-0.16-0.16-0.18-0.12
Selling, General and Administrative Excl. Other5.365.345.686.255.554.914.934.41
Research and Development3.083.133.644.552.702.482.752.47
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-5.54-5.57-5.96-6.38-5.71-5.07-5.11-4.52
Interest Expense---0.000.470.620.490.38
Unusual Expense-1.470.58-1.600.180.31-0.01-0.61-0.33
Net Income Before Taxes-3.93-5.98-4.35-6.59-6.48-5.69-5.00-4.62
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-3.93-5.98-4.35-6.59-6.48-5.69-5.00-6.28
Net Income From Continuing Operations-3.93-5.98-4.35-6.59-6.48-5.69-5.00-6.28
Net Income-5.24-7.27-5.70-7.74-7.75-6.94-6.24-7.69
EPS (Recurring)-0.60-0.66-0.99-2.63-3.45-3.25-3.13-3.71
EPS (Basic, Before Extraordinaries)-0.50-0.70-0.83-2.67-3.55-3.25-2.92-3.60
EPS (Diluted)-0.50-0.70-0.83-2.67-3.55-3.25-2.92-3.60
EBITDA-5.46-5.50-5.89-6.30-5.63-4.99-5.05-4.48
Non-Operating Income (Expense)0.130.170.01-0.020.01-0.00-0.01-0.04
Other After Tax Adjustments0.000.000.000.000.000.000.00-1.66
Stock Option Compensation Expense0.310.210.240.180.170.150.160.15
Price To Sales Ratio307.66398.06195.9379.3781.49136.78130.78135.54
Gross Margin-269.70-445.10-702.56-181.33-383.33-200.00-391.30-273.81
Operating Margin-8,389.39-10,919.61-15,279.49-8,513.33-13,590.48-6,500.00-11,102.17-10,771.43
Net Margin-7,939.39-14,258.82-14,617.95-10,316.00-18,445.24-8,900.00-13,556.52-18,300.00
Shares Outstanding7.747.727.692.892.382.152.132.13
Market Capitalization53.7961.1451.1319.1318.4730.5627.7230.50

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments3.745.484.220.180.150.03
Short Term Receivables0.050.820.250.040.000.00
Inventories1.551.711.401.290.000.00
Other Current Assets0.941.381.590.130.710.00
Total Current Assets6.289.387.461.650.860.03
Net Property, Plant & Equipment1.922.150.810.910.000.00
Total Investments and Advances0.000.000.000.00426.040.00
Intangible Assets-0.000.000.000.000.00
Deferred Tax Assets0.81-----
Other Assets0.360.000.000.000.000.09
Total Assets9.3711.548.272.56426.900.12
Short Term Debt Incl. Current Port. of LT Debt0.170.140.160.570.000.00
Accounts Payable2.921.651.551.000.000.00
Income Tax Payable---0.69--
Other Current Liabilities8.475.745.570.942.680.10
Total Current Liabilities11.567.547.292.522.680.10
Long Term Debt0.7419.520.4033.960.000.00
Provision for Risks Charges1.601.771.922.140.000.00
Deferred Tax Liabilities0.810.10----
Other Liabilities6.411.450.430.1335.940.00
Total Liabilities21.1330.3810.0538.7538.620.10
Non-Equity Reserves0.390.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-12.16-18.84-1.78-36.20388.290.02
Total Shareholders Equity-12.16-18.84-1.78-36.20388.290.02
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-12.16-18.84-1.78-36.20388.290.02
Total Liabilities & Stockholders Equity9.3711.548.272.56426.900.12
Book Value Per Share-4.20-8.83-0.95-35.7673.090.00
Tangible Book Value Per Share-4.20-8.83-0.95-35.7673.090.00
Full-Time Employees434234233
Price to Book Ratio-35.16-1.627.401.301.331.32
Return on Assets-227.29-234.14-552.73-7.42-0.12-
Return on Equity---14.59-9.04-0.13-
Return on Invested Capital--3,321.30---0.06-2.88
Quick Ratio0.411.020.830.140.320.26
Current Ratio0.541.241.020.650.320.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-20.85-23.76-20.80-29.92-15.92-0.25-0.00
Depreciation0.300.300.170.130.07--
Other Funds (Non Cash)0.013.413.3113.687.20-4.450.00
Funds from Operations-20.54-20.04-17.31-16.11-8.64-4.71-0.00
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-1.701.84-0.64-0.98-0.161.460.00
Income Taxes Payable----0.69--
Cash from Operating Activities-22.23-18.20-17.95-17.09-8.80-3.240.00
Capital Expenditures-0.20-0.18-0.98-0.15-0.220.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00-425.000.00
Purchase of Investments0.000.000.000.000.00-425.00-
Sale Or Maturity of Investments0.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities-0.20-0.18-0.98-0.15-0.22-425.000.00
Cash Dividends Paid0.00-1.82-2.450.000.000.000.00
Change in Capital Stock34.289.443.5611.850.09428.370.03
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock34.289.443.5611.850.09428.370.03
Proceedsfrom Stock Options3.706.331.7511.850.00415.870.03
Issuance or Reduction of Debt, Net-0.769.0719.089.448.000.000.00
Change in Long Term Debt-0.869.0719.08-0.560.000.000.00
Issuance of Long Term Debt0.0010.0020.000.000.000.000.00
Reduction of Long Term Debt-0.86-0.93-0.92-0.560.000.000.00
Net Financing Active Other Cash Flow-0.06-0.060.000.000.000.000.00
Other Financing Activities Uses-0.06-0.060.000.000.000.000.00
Cash from Financing Activities33.4516.6320.2021.288.09428.370.03
Exchange Rate Effect-0.000.00-0.01-0.00-0.01--
Net Change in Cash11.01-1.741.264.04-0.940.120.03
Free Cash Flow-22.44-18.38-18.93-17.24-9.02-3.240.00
Preferred Dividends (Cash Flow)--1.82-2.450.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments14.5719.6825.253.743.565.29
Short Term Receivables0.070.070.050.050.050.06
Inventories1.511.581.491.551.641.59
Other Current Assets1.110.590.890.940.510.58
Total Current Assets17.2621.9227.686.285.767.51
Net Property, Plant & Equipment1.641.741.811.922.031.96
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets---0.81--
Other Assets0.260.290.330.360.390.42
Total Assets19.1623.9529.829.378.189.90
Short Term Debt Incl. Current Port. of LT Debt0.180.130.180.170.170.20
Accounts Payable1.582.041.702.922.681.62
Other Current Liabilities12.5010.4710.338.476.146.18
Total Current Liabilities14.2712.6312.2111.568.998.00
Long Term Debt0.590.680.710.740.7828.64
Provision for Risks Charges1.501.541.551.601.681.73
Deferred Tax Liabilities---0.81--
Other Liabilities3.945.404.806.414.261.39
Total Liabilities20.3020.2519.2721.1315.7139.76
Non-Equity Reserves0.390.390.390.390.130.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-1.533.3010.16-12.16-7.66-29.86
Total Shareholders Equity-1.533.3010.16-12.16-7.66-29.86
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-1.533.3010.16-12.16-7.66-29.86
Total Liabilities & Stockholders Equity19.1623.9529.829.378.189.90
Book Value Per Share-0.200.431.32-4.20-3.22-13.87
Tangible Book Value Per Share-0.200.431.32-4.20-3.22-13.87
Full-Time Employees---43--
Price to Book Ratio-35.1618.515.03-1.57-2.41-1.02
Return on Assets-152.54-138.27-114.95-227.29-266.75-275.57
Return on Invested Capital--150.26-40.02---
Quick Ratio1.101.612.140.410.460.74
Current Ratio1.211.732.270.540.640.94

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-3.93-5.98-4.35-6.59-6.48-5.69
Depreciation0.070.070.070.080.080.09
Other Funds (Non Cash)-0.831.13-1.020.741.311.07
Funds from Operations-4.69-4.78-5.30-5.76-5.09-4.54
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.34-0.68-0.760.080.760.08
Cash from Operating Activities-5.03-5.46-6.06-5.68-4.33-4.46
Capital Expenditures-0.03-0.010.00-0.170.00-0.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.03-0.010.00-0.170.00-0.00
Cash Dividends Paid0.000.000.000.000.00-0.61
Preferred Dividends (Cash Flow)0.000.000.000.000.00-0.61
Change in Capital Stock0.100.1027.786.292.870.28
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.100.1027.786.292.870.28
Proceedsfrom Stock Options-0.100.10-2.215.920.210.20
Issuance or Reduction of Debt, Net-0.15-0.21-0.21-0.19-0.274.76
Change in Long Term Debt-0.15-0.21-0.21-0.29-0.174.76
Issuance of Long Term Debt0.000.000.000.000.005.00
Reduction of Long Term Debt-0.15-0.21-0.21-0.29-0.17-0.24
Net Financing Active Other Cash Flow0.000.000.00-0.060.000.00
Other Financing Activities Uses0.000.000.00-0.060.000.00
Cash from Financing Activities-0.05-0.1127.576.042.604.44
Exchange Rate Effect-0.00-0.00-0.000.00-0.00-0.00
Net Change in Cash-5.11-5.5721.510.18-1.73-0.03
Free Cash Flow-5.06-5.46-6.06-5.86-4.33-4.46

Revenue breakdown

Orthopedic, Prosthetic & Surgical Appliances & Supplies2024: 225.00K 2025: 241.00K
United States2024: 225.00K 2025: 241.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.94%0.1M4.6M12.48K
2026-10-151.25%0.1M4.6M11.94K
2026-09-301.08%0.0M4.6M17.00K
2026-09-151.15%0.1M4.6M36.81K
2026-08-311.32%0.1M4.6M37.74K
2026-08-141.88%0.1M4.6M39.30K
2026-07-312.13%0.1M4.6M38.60K
2026-07-151.92%0.1M4.6M36.07K
2026-06-302.15%0.1M4.6M32.28K
2026-06-152.50%0.1M4.6M20.42K
2026-05-292.52%0.1M4.6M23.49K
2026-05-152.75%0.1M4.6M29.28K
2026-04-302.97%0.1M4.6M76.77K
2026-04-152.82%0.1M4.6M77.24K
2026-03-311.53%0.1M7.7M76.73K
2026-03-131.05%0.1M7.7M71.11K
2026-02-271.24%0.1M7.7M68.38K
2026-02-131.59%0.1M7.7M71.85K
2026-01-302.44%0.0M1.8M28.69K
2026-01-152.69%0.0M1.8M36.08K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-278-KCurrent report2026-10-23SEC
2026-10-168-KCurrent report2026-10-12SEC
2026-10-078-KCurrent report2026-10-06SEC
2026-09-14SCHEDULE 13G/ASEC
2026-09-02DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-31DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-12SEC
2026-08-278-KCurrent report2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-19PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-19SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-06-308-KCurrent report2026-06-24SEC
2026-06-258-KCurrent report2026-06-19SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-19SEC
2026-06-16EFFECTEffectiveness filing by commission orderSEC
2026-06-12POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC
2026-06-12S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-044Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-05-228-KCurrent report2026-05-19SEC
2026-05-188-KCurrent report2026-05-12SEC
2026-05-15SCHEDULE 13GSEC
2026-05-14SCHEDULE 13GSEC
2026-05-11SCHEDULE 13G/ASEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-118-KCurrent report2026-05-11SEC
2026-04-218-KCurrent report2026-04-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-173Initial statement of beneficial ownership of securities2026-04-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-028.17M600
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Nantahala Capital Management, LLC19.90%
Bleichroeder LP8.13%
VANGUARD CAPITAL MANAGEMENT LLC1.14%
DSG Capital Advisors, LLC0.81%
GEODE CAPITAL MANAGEMENT, LLC0.73%
Focus Partners Wealth0.55%
VANGUARD FIDUCIARY TRUST CO0.39%
Arcus Capital Partners, LLC0.24%
ExodusPoint Capital Management, LP0.24%
NORTHERN TRUST CORP0.14%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.79%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.36%
Fidelity Extended Market Index Fund0.33%
Fidelity Nasdaq Composite Index Fund0.10%
Fidelity Series Total Market Index Fund0.08%
Fidelity Total Market Index Fund0.07%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. COCH. Cached 15 minutes.